Get started
WALGREENS BOOTS AL.DL-,01WALGREENS BOOTS AL.DL-,01WALGREENS BOOTS AL.DL-,01

WALGREENS BOOTS AL.DL-,01

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

W8A trade ideas

Walgreens Boots Alliance, Inc. | Chart & Forecast SummaryKey Indicators on Trade Set Up in General 1. Push Set Up 2. Range Set up 3. Break & Retest Set Up Notes On Session # Walgreens Boots Alliance, Inc. - Wedge Structure 1 - Wedge Structure 2 - Retracement - Wave (Failed 12345) | Confirmation Template Active Sessions on Relevant Range & Elemented Probabilities; London(Upwards) - NYC(Downwards) Conclusion | Trade Plan Execution & Risk Management on Demand; Overall Consensus | Sell On An Intraday Perspective
NASDAQ:WBAShort
by TradePolitics
Dead Cat Bounce or Future Growth Stock???I don't know. Is this a bottom or is this a value trap? Earnings are Oct 15th. Seems a bit oversold to me. They did sell shares of Cencora for 1.1 Billion in August (has 4 billion more) Walgreens will close 25% of its stores in the next 3 years Will they sell Boots UK? Or IPO it? There are potential buyers still. I used to love Walgreens - but it kinda sucks now. Is all the bad news priced in already? 13% of float is shorted (short squeeze?) Book value $15.80 LASTLY There are a shit ton of open gaps above, which WBA usually tends to fill. 1. Will buy a few lotto earnings calls. The 10/18 $7.50 in the money calls and some $10 out of the money. 2. Will buy some Jan 17 2025 $12.50 calls 3. Will buy some Jan 16 2026 $20 leaps Nothing too crazy, just looking for some positive momentum from the upcoming earnings and lets see if Wentworth can turn this ugly boat around. Lemme know what ye thinks (ye?) GLTA
NASDAQ:WBALong
by sonidofranko
3
Walgreens Stock Surges as Cost-Cutting Measures Boost StockWalgreens Boots Alliance (NASDAQ: NASDAQ:WBA ) saw its stock surge by more than 13% after announcing a major cost-cutting initiative, including the closure of 1,200 underperforming stores by 2027. The company’s fiscal fourth-quarter earnings exceeded Wall Street's expectations, which, along with these aggressive restructuring measures, contributed to investor optimism and the stock's sharp rise. This marks a significant turnaround for a company that has faced ongoing challenges in recent years, from declining pharmacy reimbursement rates to softer consumer spending and a bumpy transition into primary care. Earnings Overview Walgreens' fiscal fourth-quarter performance showed resilience amid a challenging environment. The company reported revenue of $37.55 billion, surpassing the analyst expectation of $35.76 billion, representing a 6% year-over-year increase. Adjusted earnings per share came in at 39 cents, exceeding the projected 36 cents. However, the company did report a net loss of $3 billion due to a valuation allowance, largely related to opioid settlement charges, which contrasts sharply with a loss of $180 million in the same period last year. The retail giant is navigating a "rocky fiscal 2024" with pressures from falling reimbursement rates and higher operational costs. To address these challenges, Walgreens has undertaken extensive cost-cutting efforts, including store closures, workforce reductions, and the integration of artificial intelligence to optimize its supply chain. The company successfully cut $1 billion in costs during the fiscal year, a substantial achievement that bolstered its U.S. retail pharmacy segment, according to CFO Manmohan Mahajan. These efforts helped Walgreens maintain steady growth across its key business segments, including a notable 7.1% year-over-year rise in U.S. healthcare revenue to $2.11 billion, partly driven by growth in its specialty pharmacy and primary care businesses. The decision to close 1,200 underperforming stores will further support the company’s financial health. Walgreens CEO Tim Wentworth noted that the closures will result in a healthier store base and will improve free cash flow while helping the company adapt to shifting consumer behavior. With 8,700 U.S. locations, 25% of which are unprofitable, the move to streamline operations is expected to be "immediately accretive" to adjusted earnings. Additionally, Walgreens (NASDAQ: NASDAQ:WBA ) reported growth in its international unit, which posted sales of $5.97 billion, a 3.2% year-over-year increase, beating analyst expectations of $5.81 billion. The company’s U.K.-based drugstore chain, Boots, played a key role in this growth, with sales increasing by 2.3%. Walgreens’ U.S. retail pharmacy sales also rose by 6.5% to $29.47 billion, a reflection of higher prescription drug prices and continued demand despite falling margins from reimbursement rate pressures. Technical Analysis From a technical standpoint, Walgreens’ stock is showing strong signs of recovery after a prolonged bearish trend. The stock is up 9.22% at the time of writing, and the relative strength index (RSI) has climbed to 62.48, indicating healthy momentum without yet crossing into overbought territory. For nearly a year, Walgreens (NASDAQ: NASDAQ:WBA ) has been trading in a wedge pattern, characterized by lower highs and lower lows, reflecting its struggles in the market. However, recent news and the surge in stock price have propelled NASDAQ:WBA to break above the upper trendline of this wedge, signaling a potential reversal. The regression analysis further supports this bullish outlook, showing that Walgreens (NASDAQ: NASDAQ:WBA ) is breaking out of its prolonged downtrend. The breakout is accompanied by a notable increase in trading volume, suggesting that the market has responded positively to the news of store closures and better-than-expected earnings. The next key level to watch is the stock's previous resistance zone, which, if breached, could lead to a more sustained upward movement. Outlook Walgreens (NASDAQ: NASDAQ:WBA ) is clearly undergoing a transformative period, with significant restructuring efforts aimed at streamlining operations and boosting profitability. Despite facing ongoing pressures from a challenging retail environment and falling pharmacy margins, the company’s aggressive cost-cutting, particularly the closure of 1,200 stores, is expected to be a major driver of future earnings growth. Its revenue growth, especially in the U.S. healthcare and international segments, provides further optimism for investors. While the company faces considerable challenges in the years ahead, its commitment to refocusing on profitability, combined with strategic initiatives like AI-driven supply chain optimizations and improved pharmacy benefit manager (PBM) negotiations, indicate that Walgreens is positioning itself for a stronger future. The stock's technical breakout from its long-term bearish pattern offers a compelling opportunity for investors looking for a turnaround play in the retail pharmacy sector. If Walgreens (NASDAQ: NASDAQ:WBA ) can continue this upward momentum and effectively navigate its cost-cutting initiatives, NASDAQ:WBA could see more sustained gains in the months ahead. Investors should keep an eye on upcoming earnings reports and management's progress on its store closure plan to gauge the long-term viability of this recovery.
NASDAQ:WBALong
by DEXWireNews
WBA Sing Trade UnderwayWBA seems to have completed the breakout of the Inverse HS bottoming and trend reversal pattern I discussed last week. If entry point was at close yesterday, gains are 6+% Take profits as you feel comfortable. Ultimate target upon completion of pattern yields a price target of approx. 10.50. If trend reversal is a long term chance of character move, reaching the 200DMA for a gain of 50-85% is not out of the question. Taking half positions off the table is not a bad idea. Please watch for details
NASDAQ:WBALong
by Commodity_TA_Plus
1
Significant Move Expected for Walgreens Boots AllianceToday, Walgreens Boots Alliance (WBA) is highly volatile with an IVRank of 102.6, indicating elevated implied volatility. The expected move is ±11.78% in the near term, showing potential for significant price swings. Skew across expiries suggests a stronger preference for calls, as evidenced by the CALL skew of 36.5%, particularly notable for the 11/15 expiry where the IVx is 102.7%. Despite a slight IVx decline across some expiries, the volatility remains high, signaling traders are bracing for large earnings-driven moves.
NASDAQ:WBALong
by TanukiTrade
Walgreens About to Launch While Amazon's same-day pharmacy delivery service is a new emerging threat, the biggest issue Walgreens continues to face is drug reimbursement pressures. Pharmacy benefit managers (PBMs) have created an untenable situation for pharmacies to the point where, in some instances, they lose money by filling certain prescriptions, including popular GLP-1 weight-loss drugs. The average price of Wall St is $9.9 per share, the highest is $16 and the lowest is $7.
NASDAQ:WBALong
by InvierteHoy
WBA Potincail reversal up trend move comingthere is a high probability of a bullish reversal. This assessment is supported by the following technical indicators: -Falling Wedge Pattern: The formation of a Falling Wedge pattern after a prolonged period of downward price action indicates a potential bullish reversal. -Increased Volume: Rising volume levels over the past several months suggest growing interest and potential buying pressure. -Positive Divergence: A positive divergence between price and RSI, suggests a bullish divergence and potential upward price movement. If the price breaks above the trendline resistance level around 9.55, the nearest upside targets are at 12.81 and 15.45. (SL) if a weekly close under 8. Please note that this is a technical analysis based on the information provided and should not be considered financial advice. It is always recommended to consult with a financial advisor before making any investment decisions.
NASDAQ:WBALong
by Shdeed
What Happened to Walgreens?Walgreens Boots Alliance (WBA) has essentially crashed. I think many of us know this story, seeing it across cities and towns across the country. However, based on the recent price action, who knows how much longer this will last. It currently trades at 25+ year lows. Here are a few key reasons why Walgreens stock is in a free fall: 1. E-Commerce Growth: Walgreens has lagged behind competitors like CVS and Amazon in capturing the digital health and e-commerce market. It may be too late. 2. Weak Earnings: Its latest earnings report showed lower-than-expected revenues, and the outlook for 2024 hasn’t provided much optimism. 3. Debt Load: Walgreens' acquisition of Boots and other ventures has left it with a significant debt burden, making it harder to navigate in this high-interest-rate environment. Is it a dip buy? I think the debt is too much. There don't seem to be any catalysts. A story I'll watch a little more closely...
NASDAQ:WBA
by scheplick
Walgreens Boots Alliance (WBA) is gearing up for a potent ...Walgreens Boots Alliance (WBA) is gearing up for a potential breakout, presenting an enticing opportunity for investors. Recent news indicates that Walgreens is restructuring its business model and focusing on cost-cutting measures, which could significantly enhance profitability. Additionally, the company's efforts to expand its healthcare services and improve in-store experiences align well with market trends, making it well-positioned for growth. As analysts project a possible 15% surge in the stock price, now may be the time to consider WBA as a solid investment. BOOOOOOOOOOOM...
NASDAQ:WBALong
by Maximus20000
Walgreens passive income & potential swingShares Only: Many would tell you to stay away from this sinking ship. I am diversifying my portfolio as we did very well this year. I would like exposure to a defensive stock that can possibly perform well in a recession. I would prefer some sort of reversal pattern on a weekly chart, but we don't have one. What attracts me is the 10.75% dividend and knowing I am buying WBA at the same lows from 1997. There is a daily gap fill at 15.50 which can be a swing target for swing traders. I will decide whether I want to swing this trade or hold for passive income later. WBA's chart is in a bearish channel downwards but if we could get some sort of a reversal pattern on the weekly chart, I may look to add to my position.
NASDAQ:WBA
by Betitio
Walgreens Boots Alliance, Inc. | Chart & Forecast SummaryKey Indicators on Trade Set Up in General 1. Push Set Up 2. Range Set up 3. Break & Retest Set Up Active Sessions on Relevant Range & Elemented Probabilities; * Asian(Ranging) - London(Upwards) - NYC(Downwards) * Weekend Crypto Session # Trend | Time Frame Conductive | Weekly Time Frame - General Trend - Measurement on Session * Support & Resistance * Trade Area | Focus & Motion Ahead # Position & Risk Reward | Daily Time Frame - Measurement on Session * Retracement | 0.5 & 0.618 * Extension | 0.786 & 1 Conclusion | Trade Plan Execution & Risk Management on Demand; Overall Consensus | Neutral
CAPITALCOM:WBA
by TradePolitics
WBA | A Pop is Imminent for this left for Dead StockWalgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
NASDAQ:WBALong
by DivergenceSeeker